Nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) were continuously delivered to the striatum at biologically active levels via recombinant adeno-associated viral (rAAV) gene transfer 4 -5 weeks prior to 30 min of middle cerebral artery occlusion (MCAO). The magnitude of the deficits in a battery of behavioral tests designed to assess striatal function was highly correlated to the extent of ischemic damage determined by unbiased stereological estimations of striatal neuron numbers. The delivery of neurotrophins lead to mild functional improvements in the ischemia-induced motor impairments assessed 3-5 weeks after the insult, in agreement with a small but significant increase of the survival of dorsolateral striatal neurons. Detailed phenotypic analysis demonstrated that the parvalbumin-containing interneurons were spared to a greater extent by the neurotrophin treatment as compared to the projection neurons, which agreed with the specificity for interneuron transduction by the rAAV vector. These data show the advantage of the never previously performed combination of precise quantification of the ischemia-induced neuropathology along with detailed behavioural analysis for assessing neuroprotection after stroke. We observe that intrastriatal delivery of NGF and BDNF using a viral vector system can mitigate, albeit only moderately, neuronal death following stroke, which leads to detectable functional sparing. © 2002 Elsevier Science (USA)
INTRODUCTION
Insults to the brain give rise to rapid and transient increases in the synthesis of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in cortical and hippocampal neurons, which has been interpreted as a potential neuroprotective response (Lindvall et al., 1994) . In support of this hypothesis, experimentally induced changes in the levels of BDNF or NGF have been shown to influence neuronal survival following cerebral ischemia. Thus, transgenic mice heterozygous for a deletion of the BDNF gene have been reported to exhibit increased infarct volume after middle cerebral artery occlusion (MCAO) (Endres et al., 2000) . Moreover, recombinant BDNF has been shown to reduce the ischemic damage after hypoxia-ischemia (Cheng et al., 1997; Han et al., 2000; Han & Holtzman, 2000) or MCAO (Schäbitz et al., 1997; Schäbitz et al., 2000; Yanamoto et al., 2000) when delivered to the brain prior or after the insult. Furthermore, infusion of a TrkB-Fc fusion protein, that scavenges endogenous BDNF, leads to increased vulnerability of striatal and hippocampal neurons in global forebrain ischemia (Larsson et al., 1999) . Mice, engineered to over-express NGF are less susceptible to the damaging effects of MCAO (Guegan et al., 1998 , 1999 .
